Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on Jun 01, 2021 7:05pm
147 Views
Post# 33308125

RE:RE:Will Abbott Labs Announcement....

RE:RE:Will Abbott Labs Announcement....Interesting take, Barnie1! I would agree with you except that the timeframe for this of a year to two years means that Abbott Labs is more likely to slow production down to a trickle and redirect to a more profitable product line. If they were interested in the developing world they would have already made inroads. Like all the other "Big Boys' they chose not to.

We'll see what happens in the next two weeks???

Cheers!

As travel gears up over the next year and developing countries look to restart their tourism, pre vaccine completion, a whole other niche of testing requirements could develop to protect residents from asymptomatic, vaccinated business people and tourists from the developed world. That will be the story unfolding as we move into Fall and Winter.

Barnie1 wrote: Abbott will sell their test at a loss to drive out competion. They are a huge company and will make up the loss through their other products. And that is the way the BIG BOYS stay BIG.



<< Previous
Bullboard Posts
Next >>